Citation Impact

Citing Papers

Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
2015
Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Predict Mucosal Disease Severity in Ulcerative Colitis
2017
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
2017
Ulcerative colitis
2020 Standout
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis
2018
A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review
2019
Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters
2020 Standout
Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti‐TNF therapy
2015

Works of Renáta Bor being referenced

How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system
2018
Is mucosal healing more common than clinical remission in ulcerative colitis? – Is it the truth or only a myth coming from the studies?
2015
Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
2013
Efficacy of the new infliximab biosimilar CT-P13 induction therapy in Crohn’s disease and ulcerative colitis – experiences from a single center
2015
Rankless by CCL
2026